Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD

Development of a disease‐modifying therapy to treat autosomal dominant polycystic kidney disease (ADPKD) requires well‐characterized preclinical models that accurately reflect the pathology and biochemical changes associated with the disease. Using a Pkd1 conditional knockout mouse, we demonstrate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Kelly A., Moreno, Sarah E., Smith, Laurie A., Husson, Hervé, Bukanov, Nikolay O., Ledbetter, Steven R., Budman, Yeva, Lu, Yuefeng, Wang, Bing, Ibraghimov‐Beskrovnaya, Oxana, Natoli, Thomas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926022/
https://www.ncbi.nlm.nih.gov/pubmed/27356569
http://dx.doi.org/10.14814/phy2.12846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926022/
https://www.ncbi.nlm.nih.gov/pubmed/27356569
http://dx.doi.org/10.14814/phy2.12846

Ejemplares similares